PATENT CLAIM ANALYSIS

Application Number: 15771704
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "472000"]

Abstract:
This invention relates to pharmaceutical controlled release compositions of salicylate-releasing actives for the treatment of tau protein-related neurodegenerative diseases and disorders.

Claim (Index 5):
The oral pharmaceutical composition of  claim 4 , in the form of particles, wherein the two different delayed release components each comprise a plurality of particles comprising a salicylate-releasing active ingredient coated with a coating comprising a pharmaceutically acceptable enteric polymer, and the immediate release component comprises a plurality of particles comprising a salicylate-releasing active ingredient free of any coating which substantially delays release of salicylate.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.04762
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15543199', '15010212', '10015930', '13186006', '11120139']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.732712267651011
- 35 USC 102 Novelty (BERT): 0.5090641040255981
- Combined Prediction Score: 0.7103474512884698
- Mean Citation Score: 237.953648
- Max Citation Score: 264.3504
- Similarity Product: 169.74417561779018

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test